Savvy Advisors Inc’s Novo Nordisk NVO Stock Holding History

Savvy Advisors Inc’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.6M	Sell	33,310 -1,485	-4%	-$63.8K	0.03%	383
2026 Q1	$1.28M	Buy	34,795 +1,468	+4%	+$69.6K	0.03%	368
2025 Q4	$1.7M	Sell	33,327 -15,497	-32%	-$792K	0.05%	260
2025 Q3	$2.71M	Buy	48,824 +22,138	+83%	+$1.3M	0.12%	120
2025 Q2	$1.84M	Buy	26,686 +14,672	+122%	+$998K	0.12%	126
2025 Q1	$834K	Buy	12,014 +4,891	+69%	+$404K	0.08%	196
2024 Q4	$613K	Buy	7,123 +3,395	+91%	+$367K	0.07%	215
2024 Q3	$444K	Buy	3,728 +1,524	+69%	+$203K	0.09%	196
2024 Q2	$315K	Buy	+2,204	New	+$292K	0.1%	203

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Savvy Advisors Inc's NVO Position: Q2 2026 in Review

Savvy Advisors Inc reduced its Novo Nordisk (NVO) stake by 4.3% in Q2 2026, selling an estimated $63.8K and leaving 33,310 shares worth $1.6M. The position accounts for 0.03% of the portfolio, ranked #383.

Savvy Advisors Inc first reported a position in NVO in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.71M in Q3 2025. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Savvy Advisors Inc held 33,310 shares of Novo Nordisk worth $1.6M as of Q2 2026.
Savvy Advisors Inc sold 1,485 Novo Nordisk shares in Q2 2026, an estimated $63.8K.
Novo Nordisk made up 0.03% of Savvy Advisors Inc's portfolio in Q2 2026, its #383 holding.
Savvy Advisors Inc first reported a position in Novo Nordisk in Q2 2024 and has held it in 9 quarters since.
Savvy Advisors Inc's Novo Nordisk position peaked at $2.71M in Q3 2025.
1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Savvy Advisors Inc's 13F filing for Q2 2026, filed 3 Aug 2026.